Other NAP books related by word and phrase frequencies

The following titles are likely to be of interest to you. The top keyword and keyphrase weights from this report have been compared with the equivalent lists of words and phrases for all other available NAP publications.

• The Future of Drug Safety: Promoting and Protecting the Health of the Public (2007) (ISBN 0309103045) Committee on the Assessment of the US Drug Safety System, Alina Baciu, Kathleen Stratton, Sheila P. Burke, Editors


• Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development: Workshop Summary (2012) (ISBN 0309222141) Steve Olson and Anne B. Claiborne, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Institute of Medicine


• Enhancing Food Safety:The Role of the Food and Drug Administration (2010) (ISBN 0309152739) Robert B. Wallace and Maria Oria, Editors; Committee on the Review of Food and Drug Administration's Role in Ensuring Safe Food; National Research Council


• Ethical and Scientific Issues in Studying the Safety of Approved Drugs (2012) (ISBN 0309218136) Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs; Institute of Medicine


• Challenges for the FDA: The Future of Drug Safety, Workshop Summary (2007) (ISBN 0309109868) Leslie Pray and Sally Robinson, Rapporteurs, Forum on Drug Discovery, Development, and Translation


• Accelerating the Development of New Drugs and Diagnostics: Maximizing the Impact of the Cures Acceleration Network: Workshop Summary (2012) (ISBN 0309261163) Steve Olson and Anne B. Claiborne, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy; Institute of Medicine


• Medical Devices and the Public's Health: The FDA 510(k) Clearance Process at 35 Years (2011) (ISBN 0309212421) Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process; Institute of Medicine


• Food and Drug Administration Advisory Committees (1992) (ISBN 0309048370) Richard A. Rettig, Laurence E. Earley, and Richard A. Merrill, Editors; Committee to Study the Use of Advisory Committees, Institute of Medicine


• Advancing Regulatory Science for Medical Countermeasure Development: Workshop Summary (2011) (ISBN 0309214904) Theresa Wizemann, Bruce M. Altevogt, and Anne B. Claiborne, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Forum on Medical and Public Health Preparedness for Catastrophic Events; Institute of Medicine


• Ensuring Safe Foods and Medical Products Through Stronger Regulatory Systems Abroad (2012) (ISBN 030922408X) Jim E. Riviere and Gillian J. Buckley, Editors; Committee on Strengthening Core Elements of Regulatory Systems in Developing Countries; Board on Global Health; Board on Health Sciences Policy; Institute of Medicine


• Scientific Standards for Studies on Modified Risk Tobacco Products (2012) (ISBN 0309223989) Committee on Scientific Standards for Studies on Modified Risk Tobacco Products; Institute of Medicine


• Rare Diseases and Orphan Products: Accelerating Research and Development (2011) (ISBN 0309158060) Marilyn J. Field and Thomas F. Boat, Editors; Committee on Accelerating Rare Diseases Research and Orphan Product Development; Institute of Medicine


• Public Health Effectiveness of the FDA 510(k) Clearance Process: Balancing Patient Safety and Innovation: Workshop Report (2010) (ISBN 0309158494) Theresa Wizemann, Editor; Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process; Institute of Medicine


• Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease (2010) (ISBN 0309151295) Christine M. Micheel and John R. Ball, Editors; Committee on Qualifications of Biomarkers and Surrogate Endpoints in Chronic Disease; Institute of Medicine


• The Changing Economics of Medical Technology (1991) (ISBN 030904491X) Annetine C. Gelijns and Ethan A. Halm, Editors; Committee on Technological Innovation in Medicine, Institute of Medicine